These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 2523750)

  • 1. D2 dopamine receptors in the human brain: heterogeneity based on differences in guanine nucleotide effect on agonist binding, and their presence on corticostriatal nerve terminals.
    De Keyser J; Walraevens H; De Backer JP; Ebinger G; Vauquelin G
    Brain Res; 1989 Apr; 484(1-2):36-42. PubMed ID: 2523750
    [TBL] [Abstract][Full Text] [Related]  

  • 2. D1 dopamine receptors in human putamen, frontal cortex and calf retina: differences in guanine nucleotide regulation of agonist binding and adenylate cyclase stimulation.
    De Keyser J; Dierckx R; Vanderheyden P; Ebinger G; Vauquelin G
    Brain Res; 1988 Mar; 443(1-2):77-84. PubMed ID: 2896059
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In human brain two subtypes of D1 dopamine receptors can be distinguished on the basis of differences in guanine nucleotide effect on agonist binding.
    De Keyser J; Walraevens H; Ebinger G; Vauquelin G
    J Neurochem; 1989 Oct; 53(4):1096-102. PubMed ID: 2527968
    [TBL] [Abstract][Full Text] [Related]  

  • 4. D2 dopamine receptors in calf globus pallidus: agonist high- and low-affinity sites not regulated by guanine nucleotide.
    De Keyser J; De Backer JP; Convents A; Ebinger G; Vauquelin G
    J Neurochem; 1985 Sep; 45(3):977-9. PubMed ID: 2411862
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anatomical and affinity state comparisons between dopamine D1 and D2 receptors in the rat central nervous system.
    Richfield EK; Penney JB; Young AB
    Neuroscience; 1989; 30(3):767-77. PubMed ID: 2528080
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dopamine agonist high-affinity state in solubilized D2 receptors in striatum, but not in anterior pituitary.
    Dumbrille-Ross A; Seeman P
    Biochem Pharmacol; 1987 Jul; 36(13):2095-9. PubMed ID: 2955789
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mono- and divalent cations modulate the affinities of brain D1 and D2 receptors for dopamine by a mechanism independent of receptor coupling to guanyl nucleotide binding proteins.
    Urwyler S
    Naunyn Schmiedebergs Arch Pharmacol; 1989 Apr; 339(4):374-82. PubMed ID: 2500603
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chronic estrogen treatment promotes a functional uncoupling of the D2 dopamine receptor in rat anterior pituitary gland.
    Munemura M; Agui T; Sibley DR
    Endocrinology; 1989 Jan; 124(1):346-55. PubMed ID: 2521206
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Agonist binding promotes a guanine nucleotide reversible increase in the apparent size of the bovine anterior pituitary dopamine receptors.
    Kilpatrick BF; Caron MG
    J Biol Chem; 1983 Nov; 258(22):13528-34. PubMed ID: 6643440
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Guanine nucleotides regulate both dopaminergic agonist and antagonist binding in porcine anterior pituitary.
    De Lean A; Kilpatrick BF; Caron MG
    Endocrinology; 1982 Mar; 110(3):1064-6. PubMed ID: 7056223
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lack of GTP-insensitive D2 dopamine receptors in Huntington's disease.
    De Keyser J; Roos RA; Ebinger G; Vauquelin G
    J Neurol Sci; 1989 Sep; 92(2-3):329-35. PubMed ID: 2530315
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acute in vivo amphetamine produces a homologous desensitization of dopamine receptor-coupled adenylate cyclase activities and decreases agonist binding to the D1 site.
    Roseboom PH; Gnegy ME
    Mol Pharmacol; 1989 Jan; 35(1):139-47. PubMed ID: 2563306
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Autoradiographic localization of D1 and D2 dopamine receptors in the human brain.
    De Keyser J; Claeys A; De Backer JP; Ebinger G; Roels F; Vauquelin G
    Neurosci Lett; 1988 Aug; 91(2):142-7. PubMed ID: 2972942
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Link between D1 and D2 dopamine receptors is reduced in schizophrenia and Huntington diseased brain.
    Seeman P; Niznik HB; Guan HC; Booth G; Ulpian C
    Proc Natl Acad Sci U S A; 1989 Dec; 86(24):10156-60. PubMed ID: 2574862
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ethanol administration does not alter dopamine D1 and D2 receptor characteristics in rat brain.
    Hietala J; Salonen I; Lappalainen J; Syvälahti E
    Neurosci Lett; 1990 Jan; 108(3):289-94. PubMed ID: 2137566
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interaction of [3H]spiperone with rat striatal dopamine D-2 receptors: kinetic evidence for antagonist-induced formation of ternary complex.
    Chatterjee TK; Scott CE; Vazquez DM; Bhatnagar RK
    Mol Pharmacol; 1988 Apr; 33(4):402-13. PubMed ID: 3357484
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Agonist high- and low-affinity states of the D2-dopamine receptor in calf brain. Partial conversion by guanine nucleotide.
    Wreggett KA; Seeman P
    Mol Pharmacol; 1984 Jan; 25(1):10-7. PubMed ID: 6231467
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of chronic SCH23390 treatment on the biochemical and behavioral properties of D1 and D2 dopamine receptors: potentiated behavioral responses to a D2 dopamine agonist after selective D1 dopamine receptor upregulation.
    Hess EJ; Albers LJ; Le H; Creese I
    J Pharmacol Exp Ther; 1986 Sep; 238(3):846-54. PubMed ID: 3018223
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 6-hydroxydopamine treatments enhance behavioral responses to intracerebral microinjection of D1- and D2-dopamine agonists into nucleus accumbens and striatum without changing dopamine antagonist binding.
    Breese GR; Duncan GE; Napier TC; Bondy SC; Iorio LC; Mueller RA
    J Pharmacol Exp Ther; 1987 Jan; 240(1):167-76. PubMed ID: 3100767
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Distinctions between ligand-binding sites for [3H]dopamine and D2 dopaminergic receptors characterized with [3H]spiroperidol.
    Hancock AA; Marsh CL
    Mol Pharmacol; 1984 Nov; 26(3):439-51. PubMed ID: 6238230
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.